Progyny Inc (NAS:PGNY)
$ 23.261 0.35 (1.53%) Market Cap: 2.10 Bil Enterprise Value: 1.82 Bil PE Ratio: 36.30 PB Ratio: 4.55 GF Score: 80/100

Progyny Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 04:15PM GMT
Release Date Price: $30.48 (+2.35%)
Anne Elizabeth Samuel
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome to the JPMorgan Healthcare Conference. My name is Anne Samuel, and I am the Healthcare Technology and Distribution Analyst here at JPMorgan. We are thrilled to have Progyny with us this morning. CEO, Peter Anevski is going to do a presentation. And then afterwards, we'll do Q&A with the team. If you have a question, please feel free to raise your hand. Someone will bring you a mic. I'm sure there's lots to talk about. So with that, let me turn it over to Pete.

Peter Anevski
Progyny, Inc. - CEO & Director

Okay. Thank you so much, Anne. Thanks, everybody, for joining. Michael Sturmer, our President; and Mark Livingston, our CFO, are here with me. And after the presentation, we'll do Q&A.

We're happy to be here. This is a very exciting time for Progyny, and we appreciate the opportunity to share our thoughts. We'll begin. We're going to pause here so you can take note of the caution regarding forward-looking statements and non-GAAP

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot